Min Liu, Li-Yun Ma, Qiong-Yao Li, Liang-Yu Huang, He-Ying Hu, Lan Tan, Hao Hu
{"title":"Associations of varicose veins with cerebrospinal fluid biomarkers of Alzheimer's disease pathologies in adults without dementia: the CABLE study.","authors":"Min Liu, Li-Yun Ma, Qiong-Yao Li, Liang-Yu Huang, He-Ying Hu, Lan Tan, Hao Hu","doi":"10.3389/fnagi.2025.1502154","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Previous studies have found a correlation between varicose veins (VVs) and cognitive decline, and individuals with VVs have a higher prevalence of Alzheimer's disease (AD). However, the associations between VVs and the core pathologies of AD have not yet been investigated. The research was designed to analyze the relationships between VVs and cerebrospinal fluid (CSF) biomarkers of AD pathologies.</p><p><strong>Methods: </strong>We included 1,298 participants from the Chinese Alzheimer's Biomarker and LifestylE (CABLE) database without dementia. Multiple linear regression (MLR) model was applied to assess the relationships between the VVs and CSF AD biomarkers. Then, we conducted subgroup analyses according to age, gender, education levels and <i>apolipoprotein E genotype ε4 (APOE-ε4)</i> carrier status. Additionally, mediation effects were assessed using causal mediation analyses with 10,000 bootstrapped iterations.</p><p><strong>Results: </strong>In total subjects, VVs had negative correlations with CSF Aβ<sub>42</sub> (β = -0.157, <i>p</i> = 0.038) and CSF Aβ<sub>42</sub>/Aβ<sub>40</sub> ratio (β = -0.272, <i>p</i> < 0.001), as well as positive correlations with CSF Aβ<sub>40</sub> (β = 0.170, <i>p</i> = 0.024), CSF p-tau (β = 0.192, <i>p</i> = 0.008), CSF t-tau/Aβ<sub>42</sub> ratio (β = 0.190, <i>p</i> = 0.011), and CSF p-tau/Aβ<sub>42</sub> ratio (β = 0.248, <i>p</i> = 0.001), after adjusting for age, sex, education levels and <i>APOE-ε4</i> carrier status. Subgroup analyses demonstrated that the relations between VVs and CSF AD biomarkers were more significant in female, mid-life adults (40-65 years), less-educated individuals and <i>APOE-ε4</i> non-carriers. Moreover, CSF Aβ<sub>42</sub>/Aβ<sub>40</sub> ratio might be a partial mediator of the association between VVs and p-tau pathology.</p><p><strong>Conclusion: </strong>Our study found correlations between VVs and CSF AD biomarkers, suggesting that VVs may be a potential risk factor for the development of AD.</p>","PeriodicalId":12450,"journal":{"name":"Frontiers in Aging Neuroscience","volume":"17 ","pages":"1502154"},"PeriodicalIF":4.5000,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11913850/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Aging Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fnagi.2025.1502154","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Previous studies have found a correlation between varicose veins (VVs) and cognitive decline, and individuals with VVs have a higher prevalence of Alzheimer's disease (AD). However, the associations between VVs and the core pathologies of AD have not yet been investigated. The research was designed to analyze the relationships between VVs and cerebrospinal fluid (CSF) biomarkers of AD pathologies.
Methods: We included 1,298 participants from the Chinese Alzheimer's Biomarker and LifestylE (CABLE) database without dementia. Multiple linear regression (MLR) model was applied to assess the relationships between the VVs and CSF AD biomarkers. Then, we conducted subgroup analyses according to age, gender, education levels and apolipoprotein E genotype ε4 (APOE-ε4) carrier status. Additionally, mediation effects were assessed using causal mediation analyses with 10,000 bootstrapped iterations.
Results: In total subjects, VVs had negative correlations with CSF Aβ42 (β = -0.157, p = 0.038) and CSF Aβ42/Aβ40 ratio (β = -0.272, p < 0.001), as well as positive correlations with CSF Aβ40 (β = 0.170, p = 0.024), CSF p-tau (β = 0.192, p = 0.008), CSF t-tau/Aβ42 ratio (β = 0.190, p = 0.011), and CSF p-tau/Aβ42 ratio (β = 0.248, p = 0.001), after adjusting for age, sex, education levels and APOE-ε4 carrier status. Subgroup analyses demonstrated that the relations between VVs and CSF AD biomarkers were more significant in female, mid-life adults (40-65 years), less-educated individuals and APOE-ε4 non-carriers. Moreover, CSF Aβ42/Aβ40 ratio might be a partial mediator of the association between VVs and p-tau pathology.
Conclusion: Our study found correlations between VVs and CSF AD biomarkers, suggesting that VVs may be a potential risk factor for the development of AD.
背景:先前的研究发现静脉曲张(VVs)与认知能力下降之间存在相关性,并且患有VVs的个体阿尔茨海默病(AD)的患病率更高。然而,VVs与AD核心病理之间的关系尚未被研究。该研究旨在分析VVs与AD病理的脑脊液(CSF)生物标志物之间的关系。方法:我们从中国阿尔茨海默病生物标志物和生活方式(CABLE)数据库中纳入1298名无痴呆的参与者。应用多元线性回归(MLR)模型评估VVs与CSF AD生物标志物之间的关系。然后根据年龄、性别、受教育程度和载脂蛋白E基因型ε4 (APOE-ε4)携带者情况进行亚组分析。此外,使用10,000次自举迭代的因果中介分析来评估中介效果。结果:经年龄、性别、文化程度、APOE-ε4携带者等因素调整后,VVs与CSF a - β42 (β = -0.157, p = 0.038)、CSF a - β42/ a - β40比值(β = -0.272, p < 0.001)呈负相关,与CSF a - β40 (β = 0.170, p = 0.024)、CSF p-tau (β = 0.192, p = 0.008)、CSF t-tau/ a - β42比值(β = 0.190, p = 0.011)、CSF p-tau/ a - β42比值(β = 0.248, p = 0.001)呈正相关。亚组分析显示,VVs与CSF AD生物标志物之间的关系在女性、中年成年人(40-65岁)、受教育程度较低的个体和APOE-ε4非携带者中更为显著。此外,脑脊液a β42/ a β40比值可能是VVs与p-tau病理关系的部分中介。结论:我们的研究发现VVs与脑脊液AD生物标志物之间存在相关性,提示VVs可能是AD发展的潜在危险因素。
期刊介绍:
Frontiers in Aging Neuroscience is a leading journal in its field, publishing rigorously peer-reviewed research that advances our understanding of the mechanisms of Central Nervous System aging and age-related neural diseases. Specialty Chief Editor Thomas Wisniewski at the New York University School of Medicine is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.